Dr. Charity Dean is the CEO, Founder and Chairman of The Public Health Company, a venture-backed Silicon Valley technology startup. In August 2020 Dr. Dean founded PHC Global, envisioning a commercial-grade global biosecurity platform to empower enterprises to manage biorisk at scale. Dr. Dean’s obsession with building a new solution was born out of 24 years in public health and the recognition that Silicon Valley innovations in artificial intelligence and machine learning could birth this entirely new capability.

Dr. Carter Mecher serves as the Medical Advisor for the Public Health Company. Prior to joining PHC Global, Carter served as a Senior Medical Advisor for the Office of Public Health in the U.S. Department of Veterans Affairs. In this position, Dr. Mecher played a key role in the COVID-19 outbreak response. From 2005 to 2011, he served as the Director of Medical Preparedness Policy at the White House Homeland Security Council and National Security Staff.

Dr. Joe DeRisi is a Scientific Advisor to PHC Global. He is one of the early pioneers of DNA microarray technology and whole genome expression profiling; he is nationally recognized in the field of genomic epidemiology for designing a first-of-its-kind initiative for COVID-19. Joe currently serves as Co-President of Chan Zuckerberg BioHub and is a professor of Biochemistry and Biophysics at University of California, San Francisco. He has a Bachelor of Arts in Biochemistry and Molecular Biology from University of California, Santa Cruz, and a Ph.D. in Biochemistry from Stanford University.

Dr. David Fisk is the Chief Medical Officer at The Public Health Company. Prior to joining PHC Global, Dr. Fisk served as an Infectious Disease Specialist at Sansum Clinic. He serves as the Medical Director of Infection Prevention and Control at Cottage Health, leading the infection control team at Cottage, working with physicians and hospital leaders on the COVID Incident Command Center to ensure the highest level of preparation and care for patients. In early March 2020, before the first confirmed COVID-19 case in Santa Barbara County, Dr. Fisk advised that the virus was already spreading locally before community members were observing symptoms.

Dr. Sumiko Mekaru is the Vice President of Research and Innovation at The Public Health Company. Dr. Mekaru is an epidemiologist operating at the intersection of traditional epidemiology and technology and leading cross-disciplinary teams to solve challenges in public health. Prior to joining PHC Global, Dr. Mekaru was a Life Sciences Strategy, Policy, and Operations Expert at Booz Allen Hamilton where she recently led the development of COVID-19 forecasting models for disease transmission, resource utilization, and critical events for the Department of Defense.

Dr. Emerson Tuttle is a Program and Data Manager for the Public Health Company. In this role, he supports prioritization of development priorities and critical data partnerships. Dr. Tuttle has extensive knowledge in the fields of health security and international relations. Prior to PHC Global, he served as a Regional Science Manager for the U.S. Defense Threat Reduction Agency (DTRA). Dr. Tuttle is an alumnus of the Emerging Leaders in Biosecurity (ELBI) Fellowship through the Johns Hopkins University Center for Health Security. He is a graduate of the Cummings School of Veterinary Medicine and the Fletcher School at Tufts University.

Dr. Michelle Nolan, a Principal Epidemiologist at The Public Health Company, builds products to enable real-time disease detection, risk assessment, and infectious disease forecasting. Dr. Nolan has experience developing novel surveillance systems, analyzing data to inform public health action, and conducting outbreak investigations. For almost ten years, Dr. Nolan worked at the New York City Department of Health and Mental Hygiene in the Bureau of Alcohol, Drug Use Prevention, Care and Treatment. Dr. Nolan holds a PhD in Epidemiology from Columbia University.

Shane Johnson is a Principal Epidemiologist at the Public Health Company. He built his biorisk expertise over nearly two decades working in every sector of public health – academic, institutional, government, and private – with specific focus on infectious disease and anti-microbial resistance. Prior to joining PHC Global, he was an associate and team leader with Booz Allen Hamilton, providing support for the Department of Defense and the Office of the Joint Staff Surgeon throughout the COVID-19 pandemic and establishing risk metrics and reports for those and other agencies. He holds a Masters of Public Health in epidemiology and biostatistics from the University of Minnesota.

Lamiah Adamjee is a public health professional with five years of experience in infectious disease surveillance and project management. She supported surveillance data management for COVID-19 outbreaks in correctional facilities across Los Angeles and has global health research experience in India and sub-Saharan Africa. With a robust background in epidemiology and global health, coupled with a passion for data innovation, she possesses a unique blend of expertise that enables her to effectively navigate the complex landscape of biorisk management. She holds a Masters of Science in Public Health and Bachelors of Kinesiology.

Katie Klatt has been with the Public Health Company for two years, currently serving as Product Manager. Katie’s career started with eight years practicing as a clinical nurse in Intensive Care Unit settings. Her work as a nurse inspired her to pursue a Masters in Public Health in Health Management, to gain a better understanding of public health principles and applying a business context to challenging public health problems. At the outset of the COVID-19 pandemic, she served as a nurse and product manager for Boston Emergency Medical Services, providing infection control care to staff and leading development of a software system to respond to infection control needs in real time.

Dr. Nicole Carnegie is the Director of Data Science at PHC Global. She is a biostatistician with over 15 years of experience working at the intersection of causal inference, infectious disease, and network modeling. Prior to joining PHC Global, Dr. Carnegie worked as an academic biostatistician in the area of HIV prevention and clinical trials. She is also an award-winning expert in predictive modeling, including three Atlantic Causal Inference Conference competition wins and the Innovation Award in the Fragile Families predictive modeling challenge. Dr. Carnegie completed her PhD in Statistics at the University of Washington and postdoctoral training at the Harvard School of Public Health.

Dr. Jiyeon Lee is a Senior Data Scientist at the Public Health Company, specializing in both data science and economics. With extensive training in econometrics, causal inference and time series forecasting, Dr. Lee has contributed to numerous projects related to forecasting, risk management, condition monitoring, and optimization across diverse industries including finance, trading, energy, utility, environment, and information technology, spanning regions worldwide such as Asia, Europe, and the US. Dr. Lee holds a Doctor of Philosophy in Economics from the National University of Singapore and earned a double degree in Bachelor of Arts in Economics and Psychology from Seoul National University.

Dr. Kelly Pierce is a Principal Data Scientist in Research and Innovation at The Public Health Company. Dr. Pierce brings an integrative perspective on data science, combining prior experiences in epidemiology, field ecology, and molecular biology to build diverse analytic tools with real-world utility. Prior to joining PHC Global, Dr. Pierce worked at the Texas Advanced Computing Center where she helped epidemiologists build models for real-time COVID-19 situational awareness and response planning. Dr. Pierce holds a PhD in Ecology, Evolution, and Behavior from The University of Texas at Austin.

Dr. Nick DeWind is a Principal Data Scientist at the Public Health Company. Nick develops AI and ML models at scale to extract key insights from multiple and diverse big data streams. Prior to joining PHC Global, Nick worked on COVID-19 modeling at Geosite, a Series A startup that developed and launched a pandemic decision support tool for the US Air Force. There he honed an ability to connect data and advanced analytics with customer needs. Nick was a postdoctoral fellow at University of Pennsylvania, and received his Ph.D. from Duke University in Neurobiology.

Kendall Burman serves as PHC Global’s Chief Operating Officer. Prior to joining PHC Global, Burman held leadership roles at Alloy, a data and technology start-up for the progressive political market. Burman previously served as the Deputy General Counsel for Strategic Initiatives at the Department of Commerce and as Associate White House Counsel and Special Assistant to the President in the Obama Administration. She was also a counsel in the cybersecurity and data privacy practice at Mayer Brown and served as Chief Staff Counsel for President Obama’s 2008 campaign.

Chris Latko is the Chief Technology Officer at PHC Global. He joined as a Principal Software Architect where he played a key role in building out the platform. He has over 25 years experience in the technology sector holding positions at companies he started, Fortune 500 companies, and a multitude of startups both in the United States and Japan. He has spent the last decade designing, refining, and reimplementing architectures for hypergrowth startups such as Boxfish, Paxata (acquired by DataRobot), Banjo, and Globality. Chris earned two patents for designing a streaming data ingestion/data normalization platform.